The Indian pharmaceutical sector would soon be showcasing candidate drugs for the three mentioned conditions.
Indian research and development efforts in government laboratories have a track record in making drugs for Filaria,Leprosy, and Tuberculosis available at affordable rates.The mentioned ‘candidate’ drugs are currently undergoing clinical trials.
Simultaneously, investigational new drug studies on molecules for cancer,and Thrombosis are being carried out .Production of therapeutic and preventive measures for re-emerged infectious diseases are also being done.
-The Hindu-